A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The study is designed to evaluate elements of cognitive function in subjects receiving either fesoterodine or alprazolam.

Key facts

Study ID

NCT01161472

Run by

Pfizer

People needed

20

Starts

2010-07-01

Expected to finish

2010-09-01

Last updated by the study team

2012-06-28

Who can join

Age: 65 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult healthy volunteers 65 years and over with minimum MMSE of 26

You may not qualify if…

• Prohibited concomitant medications
• Confounding medical conditions
• Clinically significant comorbid diseases
• Hypersensitivity or contraindications to fesoterodine or active control

Where it is running

• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.